Sandra Milligan Organon & Co. (OGN) insider trading activity

Sandra Milligan is Head of Research & Development of Organon & Co.. Currently has a direct ownership of 28,599 shares of OGN, which is worth approximately $436,992. The most recent transaction as insider was on May 04, 2023, when has been sold 2,168 shares (Common Stock) at a price of $24.24 per share, resulting in proceeds of $52,552. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.6K

0% 3M change

0% 12M change

Total Value Held $436,992

Sandra Milligan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 04 2023	SELL Payment of exercise price or tax liability	$52,552 $24.24 p/Share	2,168 Reduced 7.05%	28,599 Common Stock
May 04 2023	BUY Exercise of conversion of derivative security	-	4,984 Added 13.94%	30,767 Common Stock
May 01 2023	SELL Payment of exercise price or tax liability	$20,344 $24.63 p/Share	826 Reduced 3.1%	25,783 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	-	1,899 Added 6.66%	26,609 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$48,835 $23.09 p/Share	2,115 Reduced 7.88%	24,710 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	5,964 Added 18.19%	26,825 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$58,861 $25.09 p/Share	2,346 Reduced 10.11%	20,861 Common Stock
Feb 28 2023	BUY Exercise of conversion of derivative security	-	7,976 Added 25.58%	23,207 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$58,587 $32.44 p/Share	1,806 Reduced 10.6%	15,231 Common Stock
May 04 2022	BUY Exercise of conversion of derivative security	-	4,984 Added 22.63%	17,037 Common Stock
May 03 2022	SELL Payment of exercise price or tax liability	$16,842 $32.08 p/Share	525 Reduced 4.17%	12,053 Common Stock
May 03 2022	BUY Exercise of conversion of derivative security	-	1,842 Added 12.77%	12,578 Common Stock
May 01 2022	SELL Payment of exercise price or tax liability	$17,458 $32.33 p/Share	540 Reduced 4.79%	10,736 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	1,896 Added 14.39%	11,276 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$110,493 $37.57 p/Share	2,941 Reduced 23.87%	9,380 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	10,171 Added 45.22%	12,321 Common Stock

Also insider at

GOSS

Gossamer Bio, Inc. Healthcare

Director

AWH

Aspira Women's Health Inc. Healthcare

President

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Sandra Milligan

Head of Research & Development

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Value

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organon & Co.

Track Activities on OGN

Account